Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Acute/short term exposure
DNEL related information

Local effects

Acute/short term exposure
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Acute/short term exposure
DNEL related information

Workers - Hazard for the eyes

Additional information - workers

Acute / short-term exposure

 

In acute toxicity studies, carbazole has been shown to be of very low toxicity. From available studies, reliable short-term dose response relations cannot be deduced. DN(M)EL's are not to be derived because of the low acute toxicity of carbazole (see ECHA guidance on information requirements and chemical safety assessment - Chapter R.8).

 

Long-term exposure

 

No comprehensive repeated dose toxicity data are available.

In the carcinogenicity study (Section 7.7, Tsuda 1982; oral administration in diet), no toxicological endpoints except carcinogenicity are reported. Thus no dose descriptor for repeated dose toxicity is available.

 

In the developmental toxicity study (Section 7.8.2, Dutson 1997; dermal administration), exposure time is only 20 days. Administration is via dermal route with test substance dissolved in DMSO. Exposed animals are pregnant females and important toxicological endpoints (hematological, clinical parameters, organ weights) have not been examined. Deviations from standard repeated dose toxicity guidelines are assessed to be too extensive as to provide for a reliable dose descriptor for the endpoint repeated dose toxicity.

General Population - Hazard via inhalation route

Systemic effects

Acute/short term exposure
DNEL related information

Local effects

Acute/short term exposure
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Acute/short term exposure
DNEL related information

General Population - Hazard via oral route

Systemic effects

Acute/short term exposure
DNEL related information

General Population - Hazard for the eyes

Additional information - General Population

Acute / short-term exposure

 

In acute toxicity studies, carbazole has been shown to be of very low toxicity. From available studies, reliable short-term dose response relations cannot be deduced. DN(M)EL's are not to be derived because of the low acute toxicity of carbazole (see ECHA guidance on information requirements and chemical safety assessment - Chapter R.8).

 

Long-term exposure

 

No suited repeated dose toxicity data or dose descriptors are available.

 

In the carcinogenicity study (Section 7.7, Tsuda 1982; oral administration in diet), no toxicological endpoints except carcinogenicity are reported. Thus no dose descriptor for repeated dose toxicity is available.

 

In the developmental toxicity study (Section 7.8.2, Dutson 1997; dermal administration), exposure time is only 20 days. Administration is via dermal route with test substance dissolved in DMSO. Exposed animals are pregnant females and important toxicological endpoints (hematological, clinical parameters, organ weights) have not been examined. Deviations from standard repeated dose toxicity guidelines are assessed to be too extensive as to provide for a reliable dose descriptor for the endpoint repeated dose toxicity.